Rocky Hill, CT, United States of America

Laxma Reddy Kolla


Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 26(Granted Patents)


Location History:

  • Rocky Hill, CT (US) (2002)
  • Princeton Junction, NJ (US) (2012)

Company Filing History:


Years Active: 2002-2012

Loading Chart...
2 patents (USPTO):

Title: Laxma Reddy Kolla: Innovator in Pharmaceutical Chemistry

Introduction

Laxma Reddy Kolla is a notable inventor based in Rocky Hill, Connecticut, who has made significant contributions to the field of pharmaceutical chemistry. With a focus on developing innovative compounds, he holds two patents that showcase his expertise and dedication to advancing medical science.

Latest Patents

Kolla's latest patents include groundbreaking work on triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors. These novel compounds are designed to inhibit the enzyme 11-beta-hydroxysteroid dehydrogenase type I, which plays a crucial role in various diseases. The compounds are useful in treating, preventing, or slowing the progression of conditions that require this type of inhibitor therapy. Additionally, he has developed a process for creating water-soluble azole compounds, further demonstrating his innovative approach to pharmaceutical development.

Career Highlights

Laxma Reddy Kolla is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization allows him to collaborate with other talented professionals in the field, contributing to the development of life-saving medications.

Collaborations

Some of Kolla's notable coworkers include Chung-Pin H Chen and Timothy P Connolly. Their collaborative efforts in research and development have led to advancements in pharmaceutical chemistry and innovative therapeutic solutions.

Conclusion

Laxma Reddy Kolla's contributions to the field of pharmaceutical chemistry through his patents and work at Bristol-Myers Squibb highlight his role as an influential inventor. His innovative compounds and dedication to medical advancements continue to make a significant impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…